$1.61
0.053.21%
At close: -
$1.61
0.000.00%
After Hours: 4:49 PM EDT
Comments
Loading...
Latest Editas Medicine Stock News | NASDAQ:EDIT | Benzinga
Get the latest news on Editas Medicine stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Editas Medicine performance
Categories: All
Thursday, March 20, 2025
Wednesday, March 05, 2025
Tuesday, February 25, 2025
Monday, January 13, 2025
Tuesday, December 17, 2024
Monday, December 16, 2024
Friday, December 13, 2024
- RBC Capital Maintains Sector Perform on Edita...
- Walmart To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Friday
- This Toll Brothers Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
- Editas Medicine shares are trading lower afte...
- Barclays Maintains Equal-Weight on Editas Med...
- Chardan Capital Downgrades Editas Medicine to...
- Baird Maintains Outperform on Editas Medicine...
- Editas Medicine Realigns Strategy to Focus on In Vivo Gene Editing, Targets Human Proof Of Concept By 2026
- Stifel Downgrades Editas Medicine to Hold, Lo...
Thursday, December 12, 2024
Wednesday, December 11, 2024
Monday, December 09, 2024
Monday, November 25, 2024
Tuesday, November 05, 2024
Monday, November 04, 2024
Wednesday, October 23, 2024
Tuesday, October 22, 2024
Monday, October 21, 2024
Thursday, October 03, 2024
Thursday, September 19, 2024
Tuesday, September 17, 2024
Thursday, August 08, 2024
- Editas Q2 Earnings & Revenues Miss Estimates, Stock Down
- Barclays Maintains Equal-Weight on Editas Med...
- Editas Medicine shares are trading higher aft...
- Truist Securities Maintains Buy on Editas Med...
- Boot Barn To Rally Around 27%? Here Are 10 Top Analyst Forecasts For Thursday
- B of A Securities Upgrades Editas Medicine to...
